Matsunaga N - Search Results

1

Vaccinium myrtillus (Bilberry) Extracts Reduce Angiogenesis In Vitro and In Vivo.

Matsunaga N, Chikaraishi Y, Shimazawa M, Yokota S, Hara H. Matsunaga N, et al. Evid Based Complement Alternat Med. 2010 Mar;7(1):47-56. doi: 10.1093/ecam/nem151. Epub 2007 Oct 27. Evid Based Complement Alternat Med. 2010. PMID: 18955266 Free PMC article.

2

Proliferative diabetic retinopathy and relations among antioxidant activity, oxidative stress, and VEGF in the vitreous body.

Izuta H, Matsunaga N, Shimazawa M, Sugiyama T, Ikeda T, Hara H. Izuta H, et al. Among authors: matsunaga n. Mol Vis. 2010 Jan 29;16:130-6. Mol Vis. 2010. PMID: 20142849 Free PMC article.

3

A novel calpain inhibitor, ((1S)-1-((((1S)-1-Benzyl-3-cyclopropylamino-2,3-di-oxopropyl)amino)carbonyl)-3-methylbutyl)carbamic acid 5-methoxy-3-oxapentyl ester (SNJ-1945), reduces murine retinal cell death in vitro and in vivo.

Shimazawa M, Suemori S, Inokuchi Y, Matsunaga N, Nakajima Y, Oka T, Yamamoto T, Hara H. Shimazawa M, et al. Among authors: matsunaga n. J Pharmacol Exp Ther. 2010 Feb;332(2):380-7. doi: 10.1124/jpet.109.156612. Epub 2009 Nov 12. J Pharmacol Exp Ther. 2010. PMID: 19910537

4

Inhibitory actions of bilberry anthocyanidins on angiogenesis.

Matsunaga N, Tsuruma K, Shimazawa M, Yokota S, Hara H. Matsunaga N, et al. Phytother Res. 2010 Jan;24 Suppl 1:S42-7. doi: 10.1002/ptr.2895. Phytother Res. 2010. PMID: 19496063

5

Bilberry and its main constituents have neuroprotective effects against retinal neuronal damage in vitro and in vivo.

Matsunaga N, Imai S, Inokuchi Y, Shimazawa M, Yokota S, Araki Y, Hara H. Matsunaga N, et al. Mol Nutr Food Res. 2009 Jul;53(7):869-77. doi: 10.1002/mnfr.200800394. Mol Nutr Food Res. 2009. PMID: 19415665

6

Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.

Matsunaga N, Chikaraishi Y, Izuta H, Ogata N, Shimazawa M, Matsumura M, Hara H. Matsunaga N, et al. Ophthalmology. 2008 Nov;115(11):1916-22. doi: 10.1016/j.ophtha.2008.06.025. Epub 2008 Aug 21. Ophthalmology. 2008. PMID: 18718666

7

Rifampicin inhibits the retinal neovascularization in vitro and in vivo.

Chikaraishi Y, Matsunaga N, Shimazawa M, Hara H. Chikaraishi Y, et al. Among authors: matsunaga n. Exp Eye Res. 2008 Jan;86(1):131-7. doi: 10.1016/j.exer.2007.10.003. Epub 2007 Oct 14. Exp Eye Res. 2008. PMID: 18031740

8

Phosphatidylinositol inhibits vascular endothelial growth factor-A--induced migration of human umbilical vein endothelial cells.

Matsunaga N, Shimazawa M, Otsubo K, Hara H. Matsunaga N, et al. J Pharmacol Sci. 2008 Jan;106(1):128-35. doi: 10.1254/jphs.fp0071166. Epub 2008 Jan 11. J Pharmacol Sci. 2008. PMID: 18187933

9

Histopathological examination of two cases of anterior staphyloma associated with Peters' anomaly and persistent hyperplastic primary vitreous.

Matsubara A, Ozeki H, Matsunaga N, Nozaki M, Ashikari M, Shirai S, Ogura Y. Matsubara A, et al. Among authors: matsunaga n. Br J Ophthalmol. 2001 Dec;85(12):1421-5. doi: 10.1136/bjo.85.12.1421. Br J Ophthalmol. 2001. PMID: 11734512 Free PMC article.

10

Ocular and systemic features of Peters' anomaly.

Ozeki H, Shirai S, Nozaki M, Sakurai E, Mizuno S, Ashikari M, Matsunaga N, Ogura Y. Ozeki H, et al. Among authors: matsunaga n. Graefes Arch Clin Exp Ophthalmol. 2000 Oct;238(10):833-9. doi: 10.1007/s004170000177. Graefes Arch Clin Exp Ophthalmol. 2000. PMID: 11127570

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results